KRTAP19-4: A Potential Drug Target and Biomarker (G337971)

Target Name: KRTAP19-4

NCBI ID: G337971

KRTAP19-4

Other Name(s): Keratin associated protein 19-4 | KAP19.4 | keratin associated protein 19-4 | Keratin-associated protein 19-4 | KR194_HUMAN

KRTAP19-4: A Potential Drug Target and Biomarker

Keratin associated protein 19-4 (KRTAP19-4) is a protein that is expressed in various tissues, including hair, skin, and nails. It is a member of the keratin family, which is a protein that is highly conserved across different species. KRTAP19-4 is unique due to its sequence and structure, which allows it to interact with various signaling molecules.

Recent studies have suggested that KRTAP19-4 may have potential as a drug target or biomarker. Its unique structure and various functions make it an attractive target for drug development. In this article, we will discuss the potential of KRTAP19-4 as a drug target and biomarker.

Potential Drug Target

KRTAP19-4 has been shown to play a role in various signaling pathways. It has been shown to interact with various signaling molecules, including TGF-β, hedgehog, and NF-kappa-B. These signaling pathways are involved in various cellular processes, including cell growth, differentiation, and inflammation.

KRTAP19-4 has also been shown to play a role in the development and progression of various diseases, including cancer. For example, studies have shown that KRTAP19-4 is expressed in various types of cancer, including breast, lung, and ovarian cancer. Additionally, KRTAP19-4 has been shown to promote the growth and survival of cancer cells.

Given its involvement in various signaling pathways and its role in the development of cancer, KRTAP19-4 may be an attractive drug target. Drugs that target KRTAP19-4 may be able to inhibit its activity and have the potential to treat various diseases.

Biomarker

In addition to its potential as a drug target, KRTAP19-4 may also be used as a biomarker. Its unique structure and various functions make it an attractive candidate for use as a biomarker.

KRTAP19-4 has been shown to have various functions in various biological processes, including cell signaling and tissue structure. For example, studies have shown that KRTAP19-4 is involved in the development and maintenance of hair and nail growth. It is also involved in the development and maintenance of skin texture and thickness.

In addition to its functions in various biological processes, KRTAP19-4 has also been shown to have various interactions with various signaling molecules. Its unique structure and interactions with these molecules make it an attractive candidate for use as a biomarker.

Conclusion

In conclusion, KRTAP19-4 is a protein that has various functions in various biological processes. Its unique structure and interactions with various signaling molecules make it an attractive candidate for use as a drug target or biomarker.

The potential of KRTAP19-4 as a drug target or biomarker makes it an attractive target for further research. Further studies are needed to fully understand its functions and its potential as a drug or biomarker.

Protein Name: Keratin Associated Protein 19-4

Functions: In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins

The "KRTAP19-4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRTAP19-4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets